Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Apr 13, 2019 12:56pm
107 Views
Post# 29622951

RE:RE:Two new CEOs

RE:RE:Two new CEOs
Eoganacht wrote: The new CEOs are much more careful about what they say than Roger White was. Why risk going through the trial he and the company had to go through because of his inaccurate projections? The fact that Roger White believed what he said was true at the time he said it was taken into consideration by the OSC but it didn't get him off the hook. From now on we will have to be satisfied with the strategically timed and carefully phrased news releases management considers prudent, and rephrasings of the contents of those news releases by company mouthpieces.

This is why I believe the phase 2 trial really will start in early Q2.

Mthompson123 wrote: Same old lack of transparency and keeping shareholders updated. At least the Bruins won last night. Going up 2-0 in the series tomorrow night Marchand rules!!!!!




You know the OSC ruling goes far beyond Roger White believing his revenue projections were achievable. He also had been promising in his MD&A's since 2011 that the TLC-2000 would make its commercial debut within a matter of months and when it finally did win FDA approval he neglected to tell shareholders the patented Cell Sensing technology that distinguished it from their competitors was not part of the approval. Many companies miss on their financial guidance but the scope of TLT's miss gave cause for some shareholders to lodge a formal complaint to the OSC.

Bullboard Posts